2. BARTZOKIS, 2004. Age-related myelin breakdown: a developmental model of
G.
cognitive decline and Alzheimer's disease. Neurobiol. Aging 25: 5-1 8.
3. BARTZOKIGS,. 2004. Quadratic trajectories of brain myelin content: unifying construct
for neuropsychiatric disorders. Neurobiol. Aging 25: 49-62.
4. CONNORJ,.R. & S.L. MENZIES1. 996. Relationship of iron to oligodendrocytes and
myelination. Glia 17: 83-93.
5. ERB,G.L., D.L. OSTERBU&RS.M. LEVINE1.996. The distribution of iron in the brain:
a phylogenetic analysis using iron histochemistry. Brain Res. Dev. Brain Res. 93:
120-128.
6. MORATHD, .J. & M. MAYER-PROSCH2E0L01. . Iron modulates the differentiation of a
distinct population of glial precursor cells into oligodendrocytes. Dev. Biol. 237:
232-243.
7. POWERJ,., M. MAYER-PROSCHJE. LS,MITHet al. 2002. Oligodendrocyte precursor cells
from different brain regions express divergent properties consistent with the differing
time courses of myelination in these regions. Dev. Biol. 245: 362-375.
SMITH,M.A., C.A. ROTTKAMP, NUNOMUReAf al. 2000. Oxidative stress in
8. A.
Alzheimer's disease. Biochim. Biophys. Acta 1502: 139-144.
9. RONCAGLIOLMO., M. GARRIDOT,. WALTER al. 1998. Evidence of altered central
et
nervous system development in infants with iron deficiency anemia at 6 mo: delayed
maturation of auditory brainstem responses. Am. J. Clin. Nutr. 68: 683-690.
10. BARTZOKIGS,., D. SULTZERJ,. MINTZet al. 1994. In vivo evaluation of brain iron in
Alzheimer's disease and normal subjects using MRI. Biol. Psychiatry 35: 4 8 0 4 8 7 .
G., M. BECKSOND,.B. HANCEet al. 1997. MR evaluation of age-related
11. BARTZOKIS,
increase of brain iron in young adult and older normal males. Magn. Reson. Imaging
15: 29-35.
BARTZOKIS,
12. G.,D.SULTZERB,.J.CUMMINGetSal.2000.Invivoevaluationofbrainiron
in Alzheimer's disease and normal controls using magnetic resonance imaging. Arch.
Gen. Psychiatry 57: 47-53.
13. HALLGREBN.,& P. SOURANDE1R9.58. The effect of age on the non-haemin iron in the
human brain. J. Neurochem. 3: 41-5 I .
14. KLINTWORTGH.K, . 1973. Huntington's chorea-morphologic contributions of a century.
In Advances in Neurology. Vol. 1: Huntington's Chorea, 1872-1972, pp. 353-368.
Raven Press. New York.
BARTZOKIS,
15. G., J. MINTZ,D. SULTZEeRt al. 1994. In vivo MR evaluation of age-related
increases in brain iron. Am. J. Neuroradiol. 15: 1129-1 138.
16. CONNORJ,.R., B.S. SNYDERP,. AROSIO 1995. A quantitative analysis of isoel al.
ferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J.
Neurochem. 65: 7 17-724.
17. HULETS, .W., S. MENZIE&S J.R. CONNOR2.002. Ferritin binding in the developing
mouse brain follows a pattern similar to myelination and is unaffected by the jimpy
mutation. Dev. Neurosci. 24: 208-21 3.
18. GERBERM, .R. & J.R. CONNOR1.989. Do oligodendrocytes mediate iron regulation in
the human brain? Ann. Neurol. 26: 95-98.
19. TANG, Y., J.R. NYENGAARBD. ,PAKKENBEeRt Gal. 1997. Age-induced white matter changes
in the human brain: a stereological investigation. Neurobiol. Aging 18: 609-615.
20. MARNERL,., J.R. NYENGAARYD.,TANGet al. 2003. Marked loss of myelinated nerve
fibers in the human brain with age. J. Comp. Neurol. 462: 144-152.
21. HALLIWE,LBL. ,& J.M.C. GUTTERIDG1E9.88. Iron as biological pro-oxidant. IS1 Atlas
Sci. Biochem. 1: 48-52.
et al. 1999. MRI evaluation of brain
22. BARTZOKIGS.,, J.L. CUMMINGCS.,H. MARKHAM
iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn.
Reson. Imaging 17: 213-222.
23. BARTZOKIGS,., J. CUMMINGS., PERLMAN 1999. lncreased basal ganglia iron
et al.
levels in Huntington disease. Arch. Neurol. 56: 569-574.
G . & T.A. TISHLER2.000. MRI evaluation of basal ganglia ferritin iron and
24. BARTZOKIS,
neurotoxicity in Alzheimer's and Huntington's disease. Cell. Mol. Biol. 46: 821-833.
25. et al. 2000. Are hereditary hemochromatosis
MOALEMS,., M.E. PERCYD, .F. ANDREWS
mutations involved in Alzheimer disease? Am. J. Med. Genet. 93: 58-66.
